Ameriprise Financial »

Bright Minds Biosciences shares owned by Ameriprise Financial

Quarter-by-quarter ownership of Bright Minds Biosciences (DRUG) shares owned by Ameriprise Financial from 13F filings

Historical chart of Ameriprise Financial investment in Bright Minds Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Bright Minds Biosciences held by Ameriprise Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bright Minds Biosciences by Ameriprise Financial

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.7M 50k 72.97

More positions owned by Ameriprise Financial

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Inc Class A cs (GOOGL)
Broadcom (AVGO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Facebook Inc cl a (META)
Lam Research (LRCX)
iShares S&P 500 Index (IVV)
Chevron Corporation (CVX)
Alphabet Inc Class C cs (GOOG)
Wal-Mart Stores (WMT)
Johnson & Johnson (JNJ)
Visa (V)

View all positions for Ameriprise Financial

Top funds holding Bright Minds Biosciences

Henderson Group
Cormorant Asset Management
BlackRock
Vivo Capital
Braidwell
Vestal Point Capital
Adage Capital Partners GP
Perceptive Advisors
Balyasny Asset Management
Deerfield Management Company
Driehaus Capital Management
RA Capital Management
Dr. Jeffrey R. Jay, M.D.
MPM Oncology Impact Management
Ikarian Capital

View all funds holding Bright Minds Biosciences